The North America Endonucleases market benefits from growing applications in genomics and genetic engineering. Increasing use of DNA manipulation technologies and gene-editing research is supporting product adoption.
The endonucleases market size is expected to reach US$ 892.51 million by 2034 from US$ 395.07 million in 2025, registering a CAGR of 9.48% during 2026–2034. Endonucleases...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek